-
-
-
-
-
-
-
AxoGen (AXGN) Initiates Rolling Submission of BLA for Avance Nerve Graft
-
-
-
-
-
-
-
Acurx Pharmaceuticals (ACXP) Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
-
-
-
-
-
-
-
Lumos Pharma (LUMO) Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Dynavax (DVAX) Receives CRL for sBLA for Four-Dose HEPLISAV-B Regimen for Adults on Hemodialysis in the U.S.
-
-
-
-
-
-
-
Cue Health Inc. (HLTH) received warning letter from FDA about Emergency Use Authorized COVID-19 test
-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Files for Orphan Drug Designation for Intranasal Foralumab
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Provides Update on Phase 3 CheckMate -73L Trial
-
67,079 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.